Home > Insider Trading > Filing (0001138723-11-000054)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1138723	Accuray Inc	ARAY	Surgical & Medical Instruments & Apparatus (3841)	770268932

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1406456	L Theresa Dadone	1310 Chesapeake Terrace Sunnyvale CA 94089	Svp Human Resources	No	Yes	No	Yes

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2011-09-30	6,000	$0.00	33,599	No	4	A	Direct
Common Stock	Disposition	2011-10-01	1,045	$3.55	32,554	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	A	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Non-Qualified Stock Option (right to buy)	Acquisiton	2011-09-30	23,000	$0.00	23,000	$4.01

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
23,000		2021-09-30	No	4	A	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	1,000	Indirect	by Trust

Footnotes

The restricted stock units (RSUs) are released as they vest. A total of 25% of the shares subject to this grant become vested and are released on the first anniversary of the vesting commencement date and the remaining shares vest and are released at a rate of 25% a year on each anniversiary of the vesting commencement date over the remaining three years.
Shares were automatically sold in accordance with Accuray policy for all restricted stock unit (RSU) releases in order to cover tax obligations upon RSU release and is consistent with Accuray practices for all RSU releases of employees located in the United States.
The shares are held in the Carlsted Family Trust.
The shares subject to this stock option become vested and fully exercisable in equal monthly installments, ratably over a period of 48-months, beginning on October 1, 2011.